These data have demonstrated that TERT C228T mutation is frequently detected in multiple types of malignant tumors, including glioblastoma, hepatocellular carcinoma, thyroid carcinoma, and UC compared with C250T TERT mutation, except for skin melanoma (Figure 1). This evidence concerns the gene TERT and hepatocellular carcinoma.